Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05346341
Other study ID # 00010556 - 0008839
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 11, 2021
Est. completion date March 20, 2022

Study information

Verified date April 2022
Source Alexandria University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim of the current study was to evaluate the minimally invasive techniques in the management of salivary gland ductal pathologies


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date March 20, 2022
Est. primary completion date February 10, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All patients manifesting with either submandibular or parotid salivary gland ductal pathologies including: - Sialolithiasis (salivary stones). - Salivary ductal stenosis or stricture. - Children with juvenile recurrent parotitis. - Sjogren's syndrome. - Radio-iodine induced sialadenitis. Exclusion Criteria: - Patients who are unfit for surgery. - Patients with previous submandibular or parotid surgical resection. - Patients with salivary tumors either benign or malignant.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Minimally invasive techniques
All patient will be treated under general anaesthesia An appropriate gland-preserving minimally-invasive surgical procedure will be performed for all patients according to the nature and extent of the disease for either submandibular or parotid ducts. Minimally invasive techniques for ductal salivary gland pathologies include: Sialolithotomy through a simple cutdown Sialendoscopy Transoral microscopic-assisted sialolithotomy.

Locations

Country Name City State
Egypt Faculty of Dentistry, Alexandria University Alexandria

Sponsors (1)

Lead Sponsor Collaborator
Aya Sakr

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Subjective salivary gland performance This was done using a questionnaire to measure salivary score (this questionnaire is formulated by the multidisciplinary salivary gland society "MSGS"). The questionnaire consists of 20 questions divided in two groups: 13 regarding xerostomia and 7 regarding sialadenitis. Each question is scored from 0 to 10 and the total score could vary from 0 to 200 points. up to 12 months
Primary Objective salivary gland performance (salivary flow measurement) We have chosen 6 minutes as our standard time to collect saliva and we have chosen on purpose to collect saliva separately from the two parotids and jointly from the submandibular gland. A 5cmx5cm gaze is applied on the papilla of each Stenson duct and a third one is placed under the tongue. All these tampons are weighted separately after 6 minutes and the results collected. up to 12 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05151029 - Elastography in the Evaluation of Major Salivary Gland Lesions
Not yet recruiting NCT03893812 - Color Doppler and Mri Diffusion in Major Salivary Gland Masses
Active, not recruiting NCT03874572 - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth Phase 1
Recruiting NCT01762514 - A Phase II Clinical Trial on Comparison of Effectiveness and Safeness of Different Amifostine Regimens Phase 2
Completed NCT06240806 - Efficacy of Manuka Honey Oral Rinse in Treatment of Xerostomia N/A
Not yet recruiting NCT03746730 - Role of US,Doppler in Major Salivary Gland Diseases
Completed NCT04507646 - The Effectiveness of Auricular Acupuncture on Improving Secretion of Saliva Among Institutional Older Population N/A
Completed NCT01915966 - Efficacy Study of a Ginger and Cardamom Gelatin for Xerostomy in Terminally Ill Patients N/A